Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

GE MEDICAL SYSTEMS

🇫🇷France

Country: 🇫🇷France

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Spectral CT With Advanced CT Technology

Not Applicable

Completed

Conditions: CT Photon-Counting

First Posted Date: 2021-03-04

Last Posted Date: 2023-06-22

Lead Sponsor: GE Healthcare

Target Recruit Count: 27

Registration Number: NCT04781296

Locations: 🇸🇪
Karolinska University Hospital, Stockholm, Sweden

A Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training Programme in Europe

Completed

Conditions: Cognitive Impairment

First Posted Date: 2021-02-26

Last Posted Date: 2024-10-10

Lead Sponsor: GE Healthcare

Target Recruit Count: 227

Registration Number: NCT04773015

Locations: 🇦🇹
Kepler Universittsklinikum Neuromed Campus, Linz, Wagner-Jauregg-Weg, Austria
🇦🇹
Landeskrankenhaus Vocklabruck, Vöcklabruck, Austria
🇫🇮
Helsinki University Central Hospital, Helsinki, Finland

and more 7 locations

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients

Phase 1

Recruiting

Conditions: Myocardial Ischemia
Coronary Artery Disease

Interventions: Drug: Regadenoson

First Posted Date: 2020-10-27

Last Posted Date: 2025-07-09

Lead Sponsor: GE Healthcare

Target Recruit Count: 54

Registration Number: NCT04604782

Locations: 🇫🇷
Paris Public Hospitals System; Necker Hospital for Sick Children, Paris, France
🇬🇷
Mitera Hospital, Athens, Greece
🇮🇹
Bambino Gesu Children Hospital, Roma, Italy

and more 2 locations

A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes

Phase 2

Completed

Conditions: Ischemic Heart Disease
Coronary Artery Disease (CAD)

Interventions: Drug: Flurpiridaz (18F) Injection

First Posted Date: 2020-10-20

Last Posted Date: 2023-08-01

Lead Sponsor: GE Healthcare

Target Recruit Count: 38

Registration Number: NCT04594941

Locations: 🇺🇸
Indago Research and Health Center, Hialeah, Florida, United States
🇺🇸
Pioneer Clinical Studies, Miami, Florida, United States
🇺🇸
Amavita Clinical Research, LLC, North Miami Beach, Florida, United States

and more 2 locations

A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.

Phase 1

Completed

Conditions: Healthy Subjects (HS)

Interventions: Drug: DaTSCAN™ Ioflupane (123I) Injection

First Posted Date: 2020-09-25

Last Posted Date: 2023-08-02

Lead Sponsor: GE Healthcare

Target Recruit Count: 9

Registration Number: NCT04564092

Locations: 🇨🇳
Rujin hospital, affiliated to Shanghai Jiaotong University, School of Medicine, Huangpu, Shanghai, China

AMS Evaluation Study

Not Applicable

Completed

Conditions: Patient Monitoring

First Posted Date: 2020-07-15

Last Posted Date: 2021-11-03

Lead Sponsor: GE Healthcare

Target Recruit Count: 34

Registration Number: NCT04472208

Locations: 🇬🇧
Chelsea and Westminster Hospital, London, United Kingdom

A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Phase 3

Completed

Conditions: Parkinsonian Syndrome
Progressive Supranuclear Palsy (PSP)
Essential Tremor
Parkinson Disease(PD)
Multiple System Atrophy (MSA)

Interventions: Drug: DaTSCAN™ Ioflupane (123I) Injection

First Posted Date: 2019-12-10

Last Posted Date: 2023-10-16

Lead Sponsor: GE Healthcare

Target Recruit Count: 172

Registration Number: NCT04193527

Locations: 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Chaoyang District, China
🇨🇳
Peking Union Medical College Hospital, Beijing, Dongcheng District, China
🇨🇳
Nanfang Hospital, Nanfang Medical Univeristy, Guangdong, Guangzhou, China

and more 7 locations

Venue Ultrasound Evaluation - Israel

Not Applicable

Completed

Conditions: Ultrasound Exam in Emergency/Medical Care

First Posted Date: 2019-03-04

Last Posted Date: 2019-03-04

Lead Sponsor: GE Healthcare

Target Recruit Count: 53

Registration Number: NCT03861663

Locations: 🇮🇱
Rambam Health Care Center, Haifa, Israel

Use of Digital Tomosynthesis for Detection and Case Management of Scaphoid and Distal Radius Fractures: A VolumeRAD Data Collection Study

Not Applicable

Conditions: Distal Radius Fracture
Scaphoid Fracture

First Posted Date: 2019-02-27

Last Posted Date: 2020-09-30

Lead Sponsor: GE Healthcare

Target Recruit Count: 140

Registration Number: NCT03856450

Locations: 🇺🇸
University of Pennsylvania Hospital - Department of Orthopaedic Surgery, Philadelphia, Pennsylvania, United States

Study to Determine Safety and Dosage of OPTISON in Pediatric Participants

Phase 4

Completed

Conditions: Transthoracic Echocardiography
Suspected or Known Structural or Functional Cardiac Abnormality

Interventions: Drug: Optison

First Posted Date: 2018-11-14

Last Posted Date: 2024-05-17

Lead Sponsor: GE Healthcare

Target Recruit Count: 39

Registration Number: NCT03740997

Locations: 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
MCG Health, Inc., Augusta, Georgia, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy